<DOC>
	<DOCNO>NCT01826786</DOCNO>
	<brief_summary>The purpose study evaluate potential efficacy JNJ-42165279 treating anxiety disorder evaluation brain activation pattern use image technology healthy volunteer .</brief_summary>
	<brief_title>The Effects JNJ-42165279 Neural Basis Anxiety Disorders Healthy Male Volunteers</brief_title>
	<detailed_description>This single site , double-blind ( neither investigator participant know treatment participant receives ) study . The study consist screen phase ( 1-2 visit ) , treatment phase ( 4 visit ) , post treatment phase ( follow-up safety visit , 7 14 day last dose study drug ) . During screen phase , participant evaluate determine meet study eligibility criterion , include collection blood urine sample . During treatment phase , eligible participant assign chance ( like toss coin ) receive either JNJ-42165279 100 mg placebo daily 4 consecutive visit clinic . Placebo inactive substance compare drug test whether drug real effect . The potential drug treat anxiety assess Day 4 treatment phase . The primary assessment , Blood Oxygen Level Dependent Functional Magnetic Resonance Imaging ( BOLD-fMRI ) , measure brain activity pattern participant complete 3 emotionally-provoking task . Additionally , participant ' startle response ( eye blink ) evaluate two emotionally-provoking behavioral task outside scanner . Questionnaires complete evaluate participant ' mood , blood sample collect measure concentration JNJ-42165279 biomarkers drug activity . Safety monitor throughout study , include adverse event , vital sign ( blood pressure heart rate ) , 12-lead ECGs , physical examination , clinical safety laboratory , evaluation suicidal risk , Walk Turn test . The total study duration approximately 46 day .</detailed_description>
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>Inclusion criterion Good general health Body mass index 18 30 kg/m2 body weight less 50 kg Must adhere require contraception 3 month study Must agree donate sperm 3 month study Must agree donate blood 1 month study Able speak understand English fluently Exclusion criterion : Clinically significant medical psychiatric illness Any contraindication magnetic resonance image Unable pas hear test Alcohol substance abuse ; excessive nicotine caffeine use Recently receive investigational drug , vaccine , invasive medical device Unable abide protocol restriction use medication</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Anxiety Disorders</keyword>
	<keyword>Anxiety Modulation</keyword>
	<keyword>Male</keyword>
</DOC>